论文部分内容阅读
深圳康泰生物生产的几个批次重组乙型肝炎疫苗婴儿接种后,在湖南、广东、四川发生4例死亡病例,死因尚在调查中。目前,国家食药监总局、省局已经下发通知,要求暂停使用康泰生物全部批次重组乙型肝炎疫苗产品。(2013年12月23日《燕赵晚报》)点评:大连、江苏、河北等地都曾曝出疫苗生产商偷工减料导致疫苗效能不足的事件,而前两年的山西疫苗事件还让不少人心有余悸,再加上如今的4名婴儿致死事件,国产疫苗的信任度还剩下几何?
Shenzhen Kangtai biological production of several batches of recombinant hepatitis B vaccine infants in Hunan, Guangdong, Sichuan, four cases of deaths, the cause of death is still under investigation. At present, the State Food and Drug Administration, the provincial bureau has issued a circular calling for the suspension of all batches of Kangtai biological recombinant hepatitis B vaccine products. (December 23, 2013, “Yanzhao Evening News”) Comments: Dalian, Jiangsu, Hebei and other places have exposed the vaccine manufacturers cut corners and lead to inadequate vaccine effectiveness of the incident, and the first two years of the Shanxi vaccine incident also let a lot of people Lingering fear, coupled with today’s four fatal infant incidents, the trust of domestic vaccine is still the geometry?